Table 4. AUC calculations of ELISA results for patients with all-stage PDAC versus patients with benign pancreatic diseases, bootstrapped (1000 repetitions) at 95% CIs.
PDAC versus benign pancreatic diseasesCA19-9 (≥55)THBS2CA19-9 (≥55) + THBS2
nAUC95% CIAUC95% CIAUC95% CIP
Validation phase 2a
PDAC versus pancreatitis81/280.7740.710.840.7270.640.810.8420.760.920.2740
Validation phase 2b
PDAC versus pancreatitis197/550.8160.770.860.7310.670.790.8670.820.920.2450
PDAC versus IPMN197/1150.8840.860.910.7840.740.820.9520.930.970.0003
PDAC versus PNET197/300.8050.750.860.4440.360.710.7850.720.890.6502
PNET versus controls30/1400.5760.520.630.7510.670.840.7550.670.850.0089